This paper is in the following e-collection/theme issue:

Presentations, Abstracts, or Demonstrations (740) Public Health Surveillance Practice (163)

Published on in Vol 5, No 1 (2013):

Utility of Syndromic Surveillance Using Novel Clinical Data Sources

Utility of Syndromic Surveillance Using Novel Clinical Data Sources

Utility of Syndromic Surveillance Using Novel Clinical Data Sources

Authors of this article:

Rebecca Zwickl1 ;   Charles Ishikawa1 ;   Laura C. Streichert1
The full text of this article is available as a PDF download by clicking here.
Article Authors Cited by Tweetations Metrics

    Discusses the current state of syndromic surveillance using inpatient and ambulatory clinical data in the United States and the potential utility of the data. The Meaningful Use Stages 2 and 3 regulations incentivize the use of these data sources. Existing systems effectively perform a range of activities from influenza-like illness surveillance to heart disease risk factor surveillance. With further development, ambulatory and inpatient data could become an integral part of syndromic surveillance practice.